Medindia

X

TPI Receives SFDA Approval for Its Anti-Diabetic Drug Gliclazide

Friday, May 13, 2011 General News J E 4
Advertisement

For more information, please contact:

    James Jiayuan Tong M.D. Ph.D.

    Chief Financial Officer, Chief Business & Development Officer

    Director

    Tianyin Pharmaceutical Co., Inc.

    Web:     http://www.tianyinpharma.com

    Email:   Dr.Tong@tianyinpharma.com

    Tel:     +86-28-8551-6696 (Chengdu, China)

               +86-134-3655-0011 (China)

               +1-949-350-6999 (U.S.)

    Address: 23rd Floor, Unionsun Yangkuo Plaza

             No. 2, Block 3, South Renmin Road

             Chengdu, 610041

             China

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Mylan Launches Generic Version of Risperdal® M-Tab...
S
Biodel to Raise $30 Million Through Registered Dir...